Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05090358
Title Preventing High Blood Sugar in People Being Treated for Metastatic Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

Her2-receptor negative breast cancer

Therapies

Alpelisib + Fulvestrant

Alpelisib + Canagliflozin + Fulvestrant

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST